In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Polar Peptides is focused on true domestic manufacturing, premium research quality, fast Canadian shipping, and dependable customer support
If you see particulates, cloudiness, or discoloration other than pink, do not use the vial
Methylcobalamin is an active form of Vitamin B12, a vital nutrient crucial for numerous metabolic processes and essential for supporting key bodily functions
Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly